Table 2.
Averages for metabolic variables during CLT and TT in the YMD-CHO, YMD-F, and control-CHO trials
| CLT | TT | |
|---|---|---|
| FATox (g/min) | ||
| YMD-CHO | 0.76 ± 0.18*,#, | 0.70 ± 0.51*,# |
| YMD-F | 0.71 ± 0.17* | 0.36 ± 0.32 |
| Control-CHO | 0.64 ± 0.13 | 0.39 ± 0.29 |
| CHOox (g/min) | ||
| YMD-CHO | 1.06 ± 0.34 | 2.71 ± 0.75# |
| YMD-F | 1.07 ± 0.32 | 3.28 ± 0.76* |
| Control-CHO | 1.16 ± 0.19 | 2.91 ± 0.73 |
| V̇O2 (L/min) | ||
| YMD-CHO | 2.39 ± 0.32*,# | 3.56 ± 0.71*,# |
| YMD-F | 2.30 ± 0.17 | 3.34 ± 0.47* |
| Control-CHO | 2.22 ± 0.25 | 3.10 ± 0.39 |
| V̇CO2 (L/min) | ||
| YMD-CHO | 1.93 ± 0.24 | 3.15 ± 0.45* |
| YMD-F | 1.87 ± 0.12 | 3.13 ± 0.41* |
| Control-CHO | 1.84 ± 0.19 | 2.87 ± 0.35 |
| GE (%) | ||
| YMD-CHO | 19.8 ± 2.7 | 21.5 ± 4.2 |
| YMD-F | 20.9 ± 2.6 | 22.3 ± 2.5 |
| Control-CHO | 21.2 ± 2.3 | 23.4 ± 2.8 |
| RER | ||
| YMD-CHO | 0.81 ± 0.02* | 0.89 ± 0.08*,# |
| YMD-F | 0.81 ± 0.03* | 0.94 ± 0.06 |
| Control-CHO | 0.83 ± 0.02 | 0.93 ± 0.06 |
| HR (bpm) | ||
| YMD-CHO | 123 ± 10 | 161 ± 14* |
| YMD-F | 119 ± 12 | 160 ± 15* |
| Control-CHO | 122 ± 15 | 158 ± 17 |
Data are presented as mean ± SD. *P < 0.05, compared with control-CHO; #P < 0.05, compared with YMD-F; Significant condition effect (P < 0.05). CLT constant load test; TT time trial; FATox fat oxidation; CHOox carbohydrate oxidation; V̇O2 oxygen uptake; V̇CO2 carbon dioxide production; GE gross efficiency; RER respiratory exchange ratio; YMD-CHO yerba mate drink and carbohydrate meal, YMD-F yerba mate drink and fasted state, Control-CHO control (water) and carbohydrate meal